Hunt and Hess scale
Hunt and Hess scale is a grading system used to classify the severity of a subarachnoid hemorrhage (SAH) based on the patient's clinical condition. The scale was introduced in 1968 by William Hunt and Robert Hess as a way to assess the prognosis of patients with SAH and to help guide treatment decisions. The Hunt and Hess scale ranges from Grade I, indicating a mild condition, to Grade V, which signifies a severe condition with a poor prognosis.
Grades[edit | edit source]
The Hunt and Hess scale includes the following grades:
- Grade I: Asymptomatic or minimal headache and slight nuchal rigidity. No neurological deficit other than cranial nerve palsy.
- Grade II: Moderate to severe headache, nuchal rigidity, no neurological deficit other than cranial nerve palsy.
- Grade III: Drowsiness, confusion, or mild focal deficit.
- Grade IV: Stupor, moderate to severe hemiparesis, possibly early decerebrate rigidity, and vegetative disturbances.
- Grade V: Deep coma, decerebrate rigidity, moribund appearance.
Clinical Application[edit | edit source]
The Hunt and Hess scale is primarily used by healthcare professionals to quickly assess the severity of a subarachnoid hemorrhage and to make initial decisions about the best course of treatment. It is an important tool in the management of SAH patients, as it helps to predict outcomes and guide interventions. The scale is also used in research settings to stratify patients and to compare outcomes across different treatment modalities.
Limitations[edit | edit source]
While the Hunt and Hess scale is widely used, it has some limitations. The scale is somewhat subjective, as it relies on clinical judgment to assess the severity of symptoms. This can lead to variability in grading between different observers. Additionally, the scale does not take into account factors such as age, the presence of other medical conditions, or the size and location of the hemorrhage, which can also affect prognosis.
See Also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
